Skip to Main Content

New DOT Drug Testing Rules Effective in 2018

Print

On November 13, 2017, the Department of Transportation (DOT) published a final rule that, among other items, expands the Department’s current drug testing panel to include certain semi-synthetic opioids (i.e., hydrocodone, oxycodone, hydromorphone, oxymorphone).

“The opioid crisis is a threat to public safety when it involves safety-sensitive employees involved in the operation of any kind of vehicle or transport,” said Secretary Elaine L. Chao. “The ability to test for a broader range of opioids will advance transportation safety significantly and provide another deterrence to opioid abuse, which will better protect the public and ultimately save lives.”

According to the DOT website, the final rule goes into effect on January 1, 2018. 

What does this mean for employees?

Employees will also be tested for four semi-synthetic opioids (i.e., hydrocodone, oxycodone, hydromorphone, oxymorphone).  Some common names for these semi-synthetic opioids include OxyContin®, Percodan®, Percocet®, Vicodin®, Lortab®, Norco®, Dilaudid®, Exalgo®.  In addition, you will no longer be tested for MDEA.

To learn more about this final rule, visit our web page at https://www.transportation.gov/odapc/Part_40_Final_Rule_Summary_of_Changes or view the rule at https://www.transportation.gov/odapc/frpubs.

Source: transportation.gov

Material posted on this website is for informational purposes only and does not constitute a legal opinion or medical advice. Contact your legal representative or medical professional for information specific to your legal or medical needs.

Get Started

Let Your Aspirations Set the Agenda

Grow with who you know. Reach out to us today and start the conversation, so you’re better protected and prepared for what comes next.

Talk to an Advisor

man looking left